TrueWealth LLC’s Bristol-Myers Squibb BMY Stock Holding History

TrueWealth LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$146K	Buy	2,477 +1	+0%	+$60	0.06%	166
2020 Q1	$138K	Sell	2,476 -369	-13%	-$22.6K	0.07%	156
2019 Q4	$183K	Buy	2,845 +558	+24%	+$32K	0.07%	150
2019 Q3	$116K	Hold	2,287	–	–	0.05%	182
2019 Q2	$104K	Sell	2,287 -21	-0.9%	-$978	0.05%	189
2019 Q1	$110K	Sell	2,308 -2,000	-46%	-$99.6K	0.05%	188
2018 Q4	$224K	Buy	4,308 +3,000	+229%	+$161K	0.11%	114
2018 Q3	$81K	Hold	1,308	–	–	0.04%	220
2018 Q2	$72K	Buy	1,308 +172	+15%	+$9.29K	0.03%	223
2018 Q1	$72K	Sell	1,136 -50	-4%	-$3.22K	0.04%	226
2017 Q4	$73K	Buy	+1,186	New	+$74.2K	0.03%	244

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TrueWealth LLC's BMY Position: Q2 2020 in Review

TrueWealth LLC increased its Bristol-Myers Squibb (BMY) stake by 0.04% in Q2 2020, buying an estimated $60 and bringing the position to 2,477 shares worth $146K. The position accounts for 0.06% of the portfolio, ranked #166.

TrueWealth LLC first reported a position in BMY in Q4 2017 and has held it in 11 quarters since. The position peaked at $224K in Q4 2018. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

TrueWealth LLC held 2,477 shares of Bristol-Myers Squibb worth $146K as of Q2 2020.
TrueWealth LLC bought 1 Bristol-Myers Squibb share in Q2 2020, an estimated $60.
Bristol-Myers Squibb made up 0.06% of TrueWealth LLC's portfolio in Q2 2020, its #166 holding.
TrueWealth LLC first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 11 quarters since.
TrueWealth LLC's Bristol-Myers Squibb position peaked at $224K in Q4 2018.
2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.